Mirati Therapeutics, Inc.
MRTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$741 | -$582 | -$358 | -$213 |
| Dep. & Amort. | $3 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | -$5 | $0 |
| Stock-Based Comp. | $186 | $114 | $86 | $56 |
| Change in WC | -$10 | $66 | $16 | $13 |
| Other Non-Cash | -$9 | $12 | -$11 | -$3 |
| Operating Cash Flow | -$571 | -$389 | -$272 | -$148 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$10 | -$4 | -$2 |
| Net Acquisitions | -$231 | $579 | $135 | $175 |
| Inv. Purchases | -$957 | -$1,423 | -$663 | -$530 |
| Inv. Sales/Matur. | $1,187 | $844 | $527 | $356 |
| Other Inv. Act. | $231 | -$579 | -$135 | -$175 |
| Investing Cash Flow | $226 | -$589 | -$140 | -$176 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $155 | $475 | $1,204 | $328 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $167 | $505 | $1,251 | $338 |
| Financing Cash Flow | $167 | $505 | $1,251 | $338 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$178 | -$472 | $839 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $414 | $886 | $47 | $33 |
| End Cash | $236 | $414 | $886 | $47 |
| Free Cash Flow | -$575 | -$399 | -$276 | -$149 |